Alice Webb collapsed at a friend's residence in Gloucester on September 23, 2024, shortly after undergoing a non-surgical Brazilian Butt Lift. Emergency services responded around 21:00 BST, but resuscitation efforts failed and she died in the hospital the following morning. Pathologist Dr. Stephen Leadbeatter determined the cause of death was an embolisation of hyaluronic acid, with the practitioner who administered the injections, Jordan Parke, having died at a later date.
Key points
Forensic findings confirmed that Alice Webb died directly from hyaluronic acid embolisati…: Forensic findings confirmed that Alice Webb died directly from hyaluronic acid embolisation rather than an allergic reaction, blood clot, or toxicological issue.
Medical examinations showed the cosmetic filler entered the muscle, fat, and nerves of We…: Medical examinations showed the cosmetic filler entered the muscle, fat, and nerves of Webb's buttocks before traveling through her bloodstream.
The jury inquest into the circumstances surrounding the fatal cosmetic procedure is ongoi…: The jury inquest into the circumstances surrounding the fatal cosmetic procedure is ongoing at Gloucestershire Coroner's Court.
Sources checked by our analysis pipeline: 1
- Published
A "gel-like" liquid was found in blood vessels in the brain, lungs, and heart of a woman who died shortly after having a Brazilian Butt Lift (BBL) procedure, an inquest has heard.
Mother-of-five Alice Webb, 33, collapsed at a friend's house in Gloucester on 23 September 2024 and died the following day.
During a jury inquest at Gloucestershire Coroner's Court on Wednesday, Dr Stephen Leadbeatter, a Home Office forensic pathologist, said he considered her cause of death to be "embolisation of hyaluronic acid from introduction into buttocks".
Embolisation is when something is carried in the bloodstream from one part of the body to another. Hyaluronic acid was the filler used in the procedure.
More from Gloucestershire
Could you live under deep-sea pressure for 28 days?
- Published8 hours ago
How to reduce fire risks at home this Christmas
- Published9 hours ago
Hosepipe ban lifted after rain refills reservoirs
- Published6 hours ago
Webb, from Wotton-under-Edge, had been given a non-surgical BBL shortly before collapsing.
Surgical BBLs involve inserting silicone-filled implants and/or removing fat from other parts of…
The young campaigner whose family championed Northern Ireland's opt-out organ donation legislation celebrated a major milestone by running onto the pitch during an international football match. His father emphasized that the energetic appearance was made possible solely by a life-saving heart transplant received in July following an eight-year wait. The moment highlighted his dramatic physical recovery after years of enduring a severe congenital cardiac condition.
Federal regulators have provided detailed explanations regarding their decision to decline approval for Summit's pharmaceutical candidate. The move delivers critical regulatory clarity for the biotechnology sector as companies monitor agency review standards. Meanwhile, leadership at the regulatory body faces ongoing uncertainty following sudden executive staffing shifts.
Resistance from conservative lawmakers over controversial public health stances has derailed the administration's planned leadership pick for the nation's primary drug regulator. Meanwhile, clinical trial safety and efficacy concerns have forced a major pharmaceutical manufacturer to abandon an entire late-stage blood cancer program. These parallel setbacks disrupt both federal healthcare policy planning and corporate oncology pipelines.